Abstract
Background/Aims: Little research effort has so far been dedicated to the analysis of the hypothalamic-pituitary-adrenal axis of aetiologically differing subgroups of patients with panic disorder (PD). The current study aimed at a deeper understanding of the cortisol stress response in cannabis-induced PD (CIPD) patients. Methods: Matched groups of 7 PD patients (mean age ± SD: 32.95 ± 9.04 years), 7 CIPD patients (31.94 ± 8.40 years), and 7 healthy controls (HC) (31.13 ± 8.57 years) were included in the study. The Trier Social Stress Test (TSST) was used for stress induction. Salivary cortisol samples were collected and panic- and depression-related questionnaires were applied. Results: A stress response to the TSST was found in 28.6% of PD patients, in 51.1% of CIPD patients, and in 100% of HC subjects. Statistical analyses revealed a cortisol hyporesponsiveness in PD and CIPD patients. While cortisol values of PD patients and HC participants differed significantly, CIPD patients’ cortisol courses balanced between those of PD patients and HC subjects. Conclusions: Current findings show a distinctive pattern of the stress-induced cortisol reaction in CIPD patients, which is markedly different from the hormonal response in PD patients as well as HC subjects. Previous findings of cortisol hyporesponsiveness in PD patients compared to HC subjects were confirmed.
Journal Section:
Original Paper
References
1.
American Psychiatric Association
. Diagnostic and statistical manual of mental disorders
, fourth edition (DSM-IV-TR). Washington, DC: American Psychiatric Association. At risk for panic disorder. Biol Psychiatry. 2004
;57:1485-1492.2.
Jacobi
F
, Höfler
M
, Strehle
J
, Mack
S
, Gerschler
A
, Scholl
L
, et al.. Psychische Störungen in der Allgemeinbevölkerung : Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul Psychische Gesundheit (DEGS1-MH)
. Nervenarzt
. 2014
Jan
;85
(1
):77
–87
.
[PubMed]
0028-28043.
Wittchen
HU
, Jacobi
F
. Angststörungen
. Berlin
: Gesundheitsberichterstattung des Bundes
; 2004
.4.
Zvolensky
MJ
, Lewinsohn
P
, Bernstein
A
, Schmidt
NB
, Buckner
JD
, Seeley
J
, et al.. Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder
. J Psychiatr Res
. 2008
Oct
;42
(12
):1017
–23
.
[PubMed]
0022-39565.
Abelson
JL
, Khan
S
, Liberzon
I
, Young
EA
. HPA axis activity in patients with panic disorder: review and synthesis of four studies
. Depress Anxiety
. 2007
;24
(1
):66
–76
.
[PubMed]
1091-42696.
Coryell
W
, Noyes
R
Jr, Schlechte
J
. The significance of HPA axis disturbance in panic disorder
. Biol Psychiatry
. 1989
Apr
;25
(8
):989
–1002
.
[PubMed]
0006-32237.
Petrowski
K
, Wintermann
GB
, Joraschky
P
, Siepmann
M
. HPA Axis Activity under Psychosocial Stress in Patients with Acute and Remitted Panic Disorder
. Ger J Psychiatry
. 2011
;14
:72
–9
.1433-10558.
Petrowski
K
, Herold
U
, Joraschky
P
, Wittchen
HU
, Kirschbaum
C
. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses
. Psychoneuroendocrinology
. 2010
a Apr
;35
(3
):414
–21
.
[PubMed]
0306-45309.
Petrowski
K
, Wintermann
GB
, Schaarschmidt
M
, Bornstein
SR
, Kirschbaum
C
. Blunted salivary and plasma cortisol response in patients with panic disorder under psychosocial stress
. Int J Psychophysiol
. 2013
Apr
;88
(1
):35
–9
.
[PubMed]
0167-876010.
van Duinen
MA
, Schruers
KR
, Jaegers
E
, Maes
M
, Griez
EJ
. Salivary cortisol in panic: are males more vulnerable
. Neuro Endocrinol Lett
. 2004
Oct
;25
(5
):386
–90
.
[PubMed]
0172-780X11.
Stephens
MA
, Wand
G
. Stress and the HPA axis: role of glucocorticoids in alcohol dependence
. Alcohol Res
. 2012
;34
(4
):468
–83
.
[PubMed]
2168-349212.
Stinson
FS
, Ruan
WJ
, Pickering
R
, Grant
BF
. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity
. Psychol Med
. 2006
Oct
;36
(10
):1447
–60
.
[PubMed]
0033-291713.
King
GR
, Ernst
T
, Deng
W
, Stenger
A
, Gonzales
RM
, Nakama
H
, et al.. Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels
. J Neurosci
. 2011
Dec
;31
(49
):17923
–31
.
[PubMed]
0270-647414.
Ranganathan
M
, Braley
G
, Pittman
B
, Cooper
T
, Perry
E
, Krystal
J
, et al.. The effects of cannabinoids on serum cortisol and prolactin in humans
. Psychopharmacology (Berl)
. 2009
May
;203
(4
):737
–44
.
[PubMed]
0033-315815.
van Leeuwen
AP
, Creemers
HE
, Greaves-Lord
K
, Verhulst
FC
, Ormel
J
, Huizink
AC
. Hypothalamic-pituitary-adrenal axis reactivity to social stress and adolescent cannabis use: the TRAILS study
. Addiction
. 2011
Aug
;106
(8
):1484
–92
.
[PubMed]
0965-214016.
Petrowski
K
, Wichmann
S
, Kirschbaum
C
. Stress-induced pro- and anti-inflammatory cytokine concentrations in panic disorder patients
. Psychoneuroendocrinology
. 2018
Aug
;94
:31
–7
.
[PubMed]
0306-453017.
Brown
TT
, Dobs
AS
. Endocrine effects of marijuana
. J Clin Pharmacol
. 2002
Nov
;42
S1
:90S
–6S
.
[PubMed]
0091-270018.
Wittchen
HU
, Zaudig
M
, Fydrich
T
. SKID Strukturiertes Klinisches Interview für DSM-IV Achse I und II Handanweisung. SKID Strukturiertes Klinisches Interview für DSM-IV Achse I und II Handanweisung
. Göttingen
: Hogrefe
; 1997
.19.
Kirschbaum
C
, Pirke
KM
, Hellhammer
DH
. The ‘Trier Social Stress Test’—a tool for investigating psychobiological stress responses in a laboratory setting
. Neuropsychobiology
. 1993
;28
(1-2
):76
–81
.
[PubMed]
0302-282X20.
Bandelow
B
. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale
. Int Clin Psychopharmacol
. 1995
Jun
;10
(2
):73
–81
.
[PubMed]
0268-131521.
Derogatis
L
. SCL-90-R: Administration, scoring and Procedures Manual-I for the R (evised)
. Baltimore
: Version
; 1977
.22.
Geiser
F
, Imbierowicz
K
, Conrad
R
, Schilling
G
, Liedtke
R
. [Differences between patients classified as “recovered” or “improved” and “unchanged” or “deteriorated” in a psychotherapy outcome study]
. Z Psychosom Med Psychother
. 2001
;47
(3
):250
–61
.
[PubMed]
1438-360823.
Chambless
DL
, Caputo
GC
, Bright
P
, Gallagher
R
. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire
. J Consult Clin Psychol
. 1984
Dec
;52
(6
):1090
–7
.
[PubMed]
0022-006X24.
Chambless
DL
, Caputo
GC
, Jasin
SE
, Gracely
EJ
, Williams
C
. The mobility inventory for agoraphobia
. Behav Res Ther
. 1985
;23
(1
):35
–44
.
[PubMed]
0005-796725.
Foley
P
, Kirschbaum
C
. Human hypothalamus-pituitary-adrenal axis responses to acute psychosocial stress in laboratory settings
. Neurosci Biobehav Rev
. 2010
Sep
;35
(1
):91
–6
.
[PubMed]
0149-763426.
Harris
DS
, Reus
VI
, Wolkowitz
OM
, Mendelson
JE
, Jones
RT
. Repeated psychological stress testing in stimulant-dependent patients
. Prog Neuropsychopharmacol Biol Psychiatry
. 2005
Jun
;29
(5
):669
–77
.
[PubMed]
0278-584627.
Gaab
J
. PASA - Primary appraisal secondary appraisal
. Verhaltenstherapie
. 2009
;19
(2
):114
–5
. 1016-626228.
Miller
R
, Plessow
F
, Kirschbaum
C
, Stalder
T
. Classification criteria for distinguishing cortisol responders from nonresponders to psychosocial stress: evaluation of salivary cortisol pulse detection in panel designs
. Psychosom Med
. 2013
Nov-Dec
;75
(9
):832
–40
.
[PubMed]
0033-317429.
Hoehn
T
, Braune
S
, Scheibe
G
, Albus
M
. Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls
. Eur Arch Psychiatry Clin Neurosci
. 1997
;247
(5
):264
–74
.
[PubMed]
0940-133430.
Armario
A
. Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome
. Trends Pharmacol Sci
. 2010
Jul
;31
(7
):318
–25
.
[PubMed]
0165-614731.
Leyton
M
, Bélanger
C
, Martial
J
, Beaulieu
S
, Corin
E
, Pecknold
J
, et al.; N.M.K. Ng Ying Kin
. Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: possible differences between remitted panic disorder patients and healthy controls
. Biol Psychiatry
. 1996
Sep
;40
(5
):353
–60
.
[PubMed]
0006-322332.
Sinha
SS
, Coplan
JD
, Pine
DS
, Martinez
JA
, Klein
DF
, Gorman
JM
. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation
. Psychiatry Res
. 1999
May
;86
(2
):93
–8
.
[PubMed]
0165-178133.
King
A
, Munisamy
G
, de Wit
H
, Lin
S
. Attenuated cortisol response to alcohol in heavy social drinkers
. Int J Psychophysiol
. 2006
Mar
;59
(3
):203
–9
.
[PubMed]
0167-876034.
Zhang
GF
, Ren
YP
, Sheng
LX
, Chi
Y
, Du
WJ
, Guo
S
, et al.. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence
. Am J Drug Alcohol Abuse
. 2008
;34
(6
):760
–8
.
[PubMed]
0095-299035.
Block
RI
, Farinpour
R
, Schlechte
JA
. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women
. Drug Alcohol Depend
. 1991
Aug
;28
(2
):121
–8
.
[PubMed]
0376-871636.
Cone
EJ
, Johnson
RE
, Moore
JD
, Roache
JD
. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects
. Pharmacol Biochem Behav
. 1986
Jun
;24
(6
):1749
–54
.
[PubMed]
0091-305737.
Wichmann
S
, Kirschbaum
C
, Lorenz
T
, Petrowski
K
. Effects of the cortisol stress response on the psychotherapy outcome of panic disorder patients
. Psychoneuroendocrinology
. 2017
Mar
;77
:9
–17
.
[PubMed]
0306-453038.
Pariante
CM
, Lightman
SL
. The HPA axis in major depression: classical theories and new developments
. Trends Neurosci
. 2008
Sep
;31
(9
):464
–8
.
[PubMed]
0166-223639.
Stetler
C
, Miller
GE
. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research
. Psychosom Med
. 2011
Feb-Mar
;73
(2
):114
–26
.
[PubMed]
0033-317440.
Burke
HM
, Davis
MC
, Otte
C
, Mohr
DC
. Depression and cortisol responses to psychological stress: a meta-analysis
. Psychoneuroendocrinology
. 2005
Oct
;30
(9
):846
–56
.
[PubMed]
0306-453041.
Kirschbaum
C
, Kudielka
BM
, Gaab
J
, Schommer
NC
, Hellhammer
DH
. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis
. Psychosom Med
. 1999
Mar-Apr
;61
(2
):154
–62
.
[PubMed]
0033-3174© 2019 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2019
You do not currently have access to this content.
